# Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe

> **NCT02636907** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 77 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** BI 695501 Autoinjector
- **DRUG:** BI 695501 Prefilled syringe

## Key facts

- **NCT ID:** NCT02636907
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-06
- **Primary completion:** 2016-06-21
- **Final completion:** 2017-06-29
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2018-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02636907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02636907, "Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02636907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*